Synulox Palatable Tablets 50 mg (500 pack)

Synulox Palatable Tablets 50 mg (500 pack)
Zoom/View More Images

Now £140.16

Normally dispatched next day . [?] [More]

Synulox Palatable Tablets have a broad spectrum of activity against bacteria commonly found in dogs.In vitro Synulox is active against a wide range of clinically important aerobic and anaerobic bacteria, including:Gram-positive :Staphylococci (including beta-lactamase-producing strains), Clostridia... Read more
Synulox Palatable Tablets 50 mg (500 pack)

Synulox Palatable Tablets have a broad spectrum of activity against bacteria commonly found in dogs.
In vitro Synulox is active against a wide range of clinically important aerobic and anaerobic bacteria, including:
Gram-positive :Staphylococci (including beta-lactamase-producing strains), Clostridia Actinomyces, Peptostreptococcus spp., Streptococci Enterococci
Gram-negative :Bacteroides spp. (including beta-lactamase-producing strains), Escherichia coli (including beta-lactamase-producing strains), Salmonellae (including beta-lactamase-producing strains), Bordetella bronchiseptica, Campylobacter spp., Fusobacterium necrophorum, Klebsiellae, Pasteurellae, Proteus spp.
Clinically, Synulox has been shown to be effective in treating a wide range of diseases of dogs including: Skin disease (including deep and superficial pyoderma); urinary tract infection; respiratory disease involving upper and lower respiratory tract, enteritis, dental infections (e.g. gingivitis), soft tissue infections (e.g. abscesses and anal sacculitis).
Note: Synulox is not indicated for cases involving Pseudomonas spp.

Visit www.myvetmeds.co.uk / dog / antibiotics-dog / synulox-palatable-tablets-50-mg-1.htm

Product Description

About Synulox Palatable Tablets 50 mg (500 pack)

Synulox Palatable Tablets 50 mg (500 pack)

Synulox Palatable Tablets have a broad spectrum of activity against bacteria commonly found in dogs.
In vitro Synulox is active against a wide range of clinically important aerobic and anaerobic bacteria, including:
Gram-positive :Staphylococci (including beta-lactamase-producing strains), Clostridia Actinomyces, Peptostreptococcus spp., Streptococci Enterococci
Gram-negative :Bacteroides spp. (including beta-lactamase-producing strains), Escherichia coli (including beta-lactamase-producing strains), Salmonellae (including beta-lactamase-producing strains), Bordetella bronchiseptica, Campylobacter spp., Fusobacterium necrophorum, Klebsiellae, Pasteurellae, Proteus spp.
Clinically, Synulox has been shown to be effective in treating a wide range of diseases of dogs including: Skin disease (including deep and superficial pyoderma); urinary tract infection; respiratory disease involving upper and lower respiratory tract, enteritis, dental infections (e.g. gingivitis), soft tissue infections (e.g. abscesses and anal sacculitis).
Note: Synulox is not indicated for cases involving Pseudomonas spp.

Please note: images are for illustration purposes only and pack sizes/strengths and new packaging styles may not be reflected in the image shown.

Directions For Use

Directions for Use

Administration
By the oral route. Synulox palatable tablets are often accepted from the hand even by sick cats and dogs. Alternatively, the tablets may be crushed and added to a little food.
Dosage rate
12.5 mg/kg bodyweight.
Dosage frequency
The table detailed in the data sheet is intended as a guide to dispensing Synulox Palatable Tablets at the standard dose rate of 12.5 mg/kg, twice daily.
For the majority of infections, including those of the skin, urinary tract and gastrointestinal tract, the above dosing regime is effective.
Refractory cases, however, particularly those of the respiratory tract, have shown improved cure rates by doubling the dose to 25 mg/kg bodyweight twice daily. (Note that the smallest animals of 1 kg bodyweight when dosed with ? tablet will already be receiving the doubled (25 mg/kg) dose rate.)
Duration of therapy
Routine cases involving all indications: The majority of these cases respond to between 5 and 7 days therapy.
Chronic or refractory cases
In these cases, where there is considerable tissue damage, a longer course of therapy may be required in that it allows sufficient time for damaged tissue to repair. Based on clinical trials, the following durations are suggested as guidelines:
Chronic skin disease

10?20 days
Chronic cystitis

10?28 days
Respiratory disease

8?10 days

Active Ingredient

Synulox Palatable Tablets 50 mg (500 pack) ingredients

Each tablet contains clavulanic acid as potassium clavulanate and amoxicillin as Amoxicillin trihydrate in a palatable base. The composition of the two tablet sizes is as follows:
50 mg
40 mg amoxicillin and 10 mg clavulanic acid.
250 mg
200 mg amoxicillin and 50 mg clavulanic acid.

Side Effects

Side effects of Synulox Palatable Tablets 50 mg (500 pack)

For animal treatment only. Synulox Palatable Tablets should not be given to rabbits, guinea pigs, hamsters or gerbils. Caution is advised in their use in any other very small herbivores.

Additional Data

Synulox Palatable Tablets 50 mg (500 pack) specification

Specification: Detail:
Pack Size: 500 pack
Brands: Pfizer
Product Form: tablet
External Link: http://www.noahcompendium.co.uk/Pfizer_Limited/Synulox_Palatable_Tablets_50_mg_and_250_mg/-31120.html
Strength/Size: 50 mg

Reviews

Nobody has written a review about this product yet!

Write a Review

Enter the text above:

captcha image

Can't read the image?

Get a new one!

Q & A

Nobody has asked any questions about this product yet!

Ask a Question

Enter the text above:

captcha image

Can't read the image?

Get a new one!